Cite
Discovery of novel, orally active dual NK1/NK2 antagonists
MLA
Benedict J. Kosmider, et al. “Discovery of Novel, Orally Active Dual NK1/NK2 Antagonists.” Bioorganic & Medicinal Chemistry Letters, vol. 11, Oct. 2001, pp. 2769–73. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....885131fda56c66af522cb021237bb06a&authtype=sso&custid=ns315887.
APA
Benedict J. Kosmider, Herbert Barthlow, Bruce Dembofsky, Jeffrey S. Albert, William Potts, Robert F. Dedinas, David Aharony, William L. Rumsey, Russell Bialecki, Timothy Wayne Davenport, Scott Sherwood, Donald Andisik, Ashok B. Shenvi, Karin Kirkland, Keith Russell, Lihong Shen, Gerard M. Koether, David Stollman, Cyrus John Ohnmacht, & Bernstein Peter Robert. (2001). Discovery of novel, orally active dual NK1/NK2 antagonists. Bioorganic & Medicinal Chemistry Letters, 11, 2769–2773.
Chicago
Benedict J. Kosmider, Herbert Barthlow, Bruce Dembofsky, Jeffrey S. Albert, William Potts, Robert F. Dedinas, David Aharony, et al. 2001. “Discovery of Novel, Orally Active Dual NK1/NK2 Antagonists.” Bioorganic & Medicinal Chemistry Letters 11 (October): 2769–73. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....885131fda56c66af522cb021237bb06a&authtype=sso&custid=ns315887.